Effect of Small Bowel Bacterial Overgrowth on the Immunogenicity of Single‐Dose Live Oral Cholera Vaccine CVD 103‐HgR
Author(s) -
Rosanna Lagos,
Alessio Fasano,
Steven S. Wasserman,
Valeria Prado,
Oriana San Martin,
Paulina Linares Abrego,
Genevieve A. Losonsky,
Silvia Alegria,
Myron Levine
Publication year - 1999
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/315051
Subject(s) - seroconversion , medicine , cholera , cholera vaccine , diarrhea , gastroenterology , titer , lactulose , immunogenicity , immunology , vibrio cholerae , antibody , virology , biology , bacteria , genetics
Several live oral vaccines (polio, bovine rotavirus, CVD 103-HgR cholera) are less immunogenic in developing than in industrialized countries. It was hypothesized that proximal small bowel bacterial overgrowth (common in children in less developed countries but rare in industrialized settings) diminishes the vibriocidal antibody response to CVD 103-HgR. In total, 202 fasting Santiago schoolchildren aged 5-9 years had lactulose breath H2 tests to detect proximal small bowel bacteria 1 day before ingesting CVD 103-HgR. Florid small bowel overgrowth was observed in 10 (5.6%) of 178 analyzable children. In children with florid overgrowth, vibriocidal seroconversion differed little from other children (60% vs. 67%), but the geometric mean titer was lower (160 vs. 368; P=.25). By logistic regression, increased peak breath H2 at small bowel time points was associated with diminished seroconversion (P=.04), as was the interaction of H2 value and weight (children >25 kg had lower seroconversion rates among subjects with heaviest overgrowth).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom